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Background: UK migrants born in intermediate to high prevalence areas for blood borne viruses (BBV) including
hepatitis B, hepatitis C and HIV are at increased risk of these infections. National guidance from Public Health
England (PHE) and National Institute for Health and Care Excellence (NICE) recommends primary care test this
population to increase diagnoses and treatment. We aimed to investigate primary care professionals’ knowledge of
entitlements, and perceptions of barriers, for migrants accessing healthcare, and their policies, and reported
practices and influences on provision of BBV testing in migrants.
Methods: A pre-piloted questionnaire was distributed between October 2017 and January 2018 to primary care
professionals attending the Royal College of General Practitioners and Best Practice in Primary Care conferences, via
a link in PHE Vaccine Updates and through professional networks.
Survey results were analysed to give descriptive statistics, and responses by respondent characteristics: profession,
region, practice size, and frequency of seeing migrant patients. Responses were considered on a per question basis
with response rates for each question presented with the results.
Results: Four hundred fourteen questionnaires were returned with responses varying by question, representing an
estimated 5.7% of English GP practices overall. Only 14% of respondents’ practices systematically identified migrant
patients for testing. Universal opt-out testing was offered to newly registering migrant patients by 18% of
respondents for hepatitis B, 17% for hepatitis C and 21% for HIV. Knowledge of healthcare entitlements varied;
fewer clinical staff knew that general practice consultations were free to all migrants (76%) than for urgent care
(88%). Performance payment structure (76%) had the greatest reported influence on testing, followed by PHE and
Clinical Commissioning Group recommendations (73% each). Language and culture were perceived to be the
biggest barriers to accessing care.
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Conclusions: BBV testing for migrant patients in primary care is usually ad hoc, which is likely to lead to testing
opportunities being missed. Knowledge of migrants’ entitlements to healthcare varies and could affect access to
care. Interventions to improve professional awareness and identification of migrant patients requiring BBV testing
are needed to reduce the undiagnosed and untreated burden of BBVs in this vulnerable population.
Keywords: Hepatitis B, Hepatitis C, HIV, Blood borne virus, Testing, Screening, General practice, Migrants, Healthcare
access, UKBackground
Migrants in the UK from intermediate or high preva-
lence areas for HIV, hepatitis B (HBV) and hepatitis C
(HCV) are at increased risk of these infections compared
to the UK-born population, and experience a dispropor-
tionate burden of disease [1–3]. In 2017 almost half
(49%) of newly diagnosed cases of HIV among hetero-
sexuals were among black Africans or heterosexuals
born in a high prevalence country [2] and an estimated
95% of new chronic HBV infections in the UK are
among individuals who probably acquired their infection
overseas in endemic countries, often perinatally or in
childhood [4]. For all three blood borne viruses (BBV)
the undiagnosed fraction remains high, with a high pro-
portion of infections diagnosed late, potentially contrib-
uting to avoidable morbidity and mortality and increased
risk of onward transmission [5–8].
In 2016, the UK government signed up to the World
Health Organisation (WHO) goal of eliminating viral
hepatitis as a public health threat by 2030 [9]. HBV and
HCV testing in primary care for migrants from countries
with intermediate or high prevalence (> 2%) has been
recommended by National Institute for Health and Care
Excellence (NICE) guidance since 2012 [10], and since
2018 European Centre for Disease Prevention and Con-
trol (ECDC) recommends screening newly arrived mi-
grants for BBV [11]. Although surveillance data indicates
that an increasing proportion of BBV diagnoses take
place in primary care, evidence suggests a low propor-
tion of eligible migrants receive the recommended BBV
testing in this setting [12, 13].
Language, stigma and poor knowledge and under-
standing of disease create barriers for migrants to acces-
sing testing and treatment for viral hepatitis [14, 15] and
migrants often experience discrimination and bureau-
cratic obstacles when trying to access healthcare [16,
17]. In August 2017 UK healthcare entitlements for mi-
grants changed and the list of chargeable services was
expanded [18, 19]. While many services, including pri-
mary care, are still free to all migrants, for others a pa-
tient should now be deemed ordinarily resident in the
UK to access services for free. Sexual health, family plan-
ning, GP and nurse consultations in primary care, emer-
gency department (ED) and walk-in centres, andtreatment of mental and physical conditions caused by
torture, female genital mutilation (FGM), domestic or
sexual violence are free to all migrants, while communic-
able disease diagnosis and treatment is free to all for a
list of specified diseases, including HIV, viral hepatitis,
TB and Middle East respiratory syndrome [18–20]. For
surgery or outpatient services in secondary care, a pa-
tient should be deemed ordinarily resident in the UK to
access the service free of charge. This additional com-
plexity may lead to uncertainty among both migrants
and professionals about entitlements, and could create
additional barriers to accessing services.
We, therefore, conducted a national survey to under-
stand primary care staff’s knowledge, attitudes, policies
and practice regarding BBVs in migrant patients, influ-
ences on these, and their perceptions of the barriers for
migrants in accessing healthcare.
Methods
Study design
A cross-sectional survey conducted among primary care
staff in England.
Study population
The target population for this study were primary care
staff working in general practices in England. All pri-
mary care staff were eligible for inclusion, but it was ex-
pected that respondents would primarily be general
practitioners (GPs) and practice nurses.
Sampling procedures
A convenience sampling approach was used, with survey
participants recruited through several routes during Oc-
tober 2017. Firstly, the link to the online survey was cir-
culated via primary care networks of local Public Health
England (PHE) Health Protection Teams across England.
Secondly, the link to the online survey was circulated in
the PHE publication Vaccine Updates, a newsletter pri-
marily subscribed to by general practice professionals
with distribution ~ 46,000. These two routes were used
opportunistically and in parallel in order to access pri-
mary care professionals, as we did not have access to an-
other primary care network with equivalent coverage
across England.
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General Practitioners (RCGP) annual conference in Liv-
erpool and the Best Practice in Primary Care conference
in Birmingham, both in October 2017. Attendees were
approached and asked to participate in the survey via
tablet devices, or offered shorter paper versions of the
survey to take away and return once completed.
Due to the timeframe and budget of the project, par-
ticipants were not followed up to respond to the survey,
and the online survey was closed in January 2018.
Data collection
The survey was created as an online questionnaire using
SelectSurvey.net™ software (ClassApps LLC, Kansas City,
Missouri) and responses were exported into Excel for
analysis. Shorter paper versions of the survey were also
distributed among participants attending the two pri-
mary care conferences. Responses from paper surveys
were manually input into Excel by the lead author.
Questionnaire design
The questionnaire was developed at PHE in collabor-
ation with a project group of clinicians, academic GPs
and qualitative researchers and piloted before launch
with a group of 4 academic GPs.
The questionnaire consisted of 37 questions covering
the following topics.
1. Respondent and practice characteristics
2. Clinical questions analysed for clinical staff (GPs
and nurses) only: Knowledge of migrants’
entitlements to health services; Issues considered
for newly registering migrant patients; Knowledge
of testing serology; Management of patients
diagnosed with hepatitis B and C; Incentives /
motivation for BBV testing
3. Practice policy questions analysed for all
respondents: Practice policy for offering BBV
testing to migrants; Identification of migrants for
BBV testing; Recording of routine data
4. Barriers questions analysed for all respondents:
Perceived barriers for migrants to accessing
healthcare across the care pathway: Healthcare;
BBV testing in primary care; Secondary care for
patients with BBV; Barriers for asylum seekers
The full questionnaire took approximately 17 min to
complete (see additional file 1 for full online question-
naire and additional file 2 for shorter paper question-
naire). Most questions were multiple choice, apart from
those relating to barriers, practice size and practice
population which were free text.
To investigate knowledge of healthcare entitlements
respondents were asked, as of August 2017, whichservices were free irrespective of migration status, using
legislation and implementation guidelines to define cor-
rect responses [18, 19].
Respondents were asked about location of practice and
professional role. No additional respondent characteris-
tics were sought as the focus of the survey was on prac-
tice, not individual characteristics.Definitions
A migrant is defined as someone who changes their
country of usual residence, in whatever manner, for
whatever reason and irrespective of their legal status.
The UN defines a permanent migrant as someone who
moves to a country for a period of 12 or more months,
often for work, education or joining family, effectively
making it their new country of usual residence [21]. A
refugee is defined as someone who has fled their home
country for reasons of feared persecution, conflict, gen-
eralised violence or other circumstances that have ser-
iously disturbed public order and are seeking protection
in another country [21]. In the UK, for a person to be of-
ficially recognised as a refugee they first have to make a
claim for asylum and have this accepted by the govern-
ment. An asylum seeker is a person who seeks safety
from persecution or serious harm in a country other
than their own and has formally applied for asylum (i.e.
refugee status) from that country, but is awaiting a deci-
sion on their application [22].
A definitions sheet was provided with the survey to
help respondents understand terms relating to migration
which also included refused asylum seeker and undocu-
mented migrant (not specifically mentioned in the ques-
tionnaire) (additional file 3).
Definitions of other terms used are as follows: Clinical
staff: respondents who identified their role as either GP
(GP partner, Salaried GP, Locum GP, or ‘other’ and spe-
cified GP), or nurse (Practice Nurse or ‘other’ and speci-
fied nurse). In questions relating to practice policy for
BBV testing, new migrants refer to newly registering pa-
tients who were migrants from outside the UK (regard-
less of when they had migrated), and existing migrants
refer to patients already registered with the practice who
had ever migrated from outside the UK. When asking
about practice characteristics, the proportion of new mi-
grants on a practice list was defined as migrants regis-
tered with the practice who had lived in the UK for 5
years or less, regardless of when they registered.
The roles of GPs and nurses in the diagnosis and man-
agement of BBVs vary by practice. Practice nurses
undertake a range of nursing assessments and provide
appropriate care / treatment in conjunction with GPs ac-
cording to practice policy and protocols and are likely to
be responsible for vaccination and testing, whereas GPs
Roche et al. BMC Public Health          (2021) 21:336 Page 4 of 23would usually be responsible for clinical diagnoses and
referrals to secondary care.
Practice size was defined as small, medium or large
using tertiles of practice populations in England reported
by NHS Digital for December 2017 [23].
Data analysis
Results were collated and de-duplicated using email ad-
dresses. Practice names were checked to identify if there
were multiple respondents from the same practice, but
these were not de-duplicated as responses differed and
were from different professionals.
Due to the methods used to circulate the survey via an
e-bulletin to which practices subscribe, it was not pos-
sible to calculate a formal response rate. Instead, the
number of responses as a proportion of GP practices in
England (based on NHS data from 2017) was calculated
to provide an indication of the proportion of England
GP practices represented in responses [23].
Results were analysed in Excel and R for overall de-
scriptive statistics (percentages and 95% confidence in-
tervals (CI)) and then stratified by respondent and
practice characteristics. Responses for clinical knowledge
and practice questions were restricted to those who gave
their role as GP or nurse and stratified by profession.
Responses for practice policy questions were analysed
for all respondents, and stratified by region, frequency of
seeing migrant patients, and practice size.
To assess the statistical significance of differences in
responses to questions, and for differences by stratified
analysis, variables were dichotomised where required be-
fore performing Chi squared tests. Where this was done,
the dichotomous outcome is highlighted in bold in re-
sults tables. Fishers exact tests were used where the
cross-tabulation did not meet the criteria for Chi
squared tests. Differences were considered statistically
significant where p < 0.05.
Free text responses on barriers were grouped by the-
matic analysis into 10 themes: language/culture, patient
information/knowledge, staff information/knowledge,
psychological, accommodation, prejudice/discrimination,
patient financial, organisational resource, geographical,
and service/organisational issues.
Each question had a different response rate, and de-
scriptive statistics were based on the number of respon-
dents for each question, which are presented with the
results.
Results
Respondent and practice characteristics
The survey was circulated through the PHE Vaccine Up-
dates circulation list, although it is not known how many
will have actively read this, and others may have been
forwarded the survey link by contacts. Afterdeduplication 414 responses were obtained; 16 paper
and 398 online, an estimated 5.7% response rate, based
on the number of GP practices in England. The majority
of responses came from circulation of the survey link as
response at conferences was poor; no attendees com-
pleted the online survey on the day, and only 16 paper
surveys were returned. Where practice name was re-
ported (145 respondents), there were 3 practices that
each had 2 respondents, all other practices were unique.
Most respondents were practice nurses (49%, 202/414)
and GPs (40%, 165/414) with the highest responses from
the Midlands (21%, 86/414), the South East (16%, 65/
414) and London (15%, 63/414) (Table 1). Responses
were equally distributed among those who reported they
saw migrant patients frequently (34%, 108/317), some-
times (33%, 103/317) and rarely (33%, 106/317) (77% re-
sponse rate).
Practice characteristics were poorly completed; only
151 (38%) respondents reported their practice size and
of these 26% (39/151) were small (< 5280 patients), 28%
(42/151) were medium (5280–9300 patients) and 46%
(70/151) were large (> = 9300 patients). Of the 79 (20%)
respondents who reported the proportion of new mi-
grants (< 5 years in the UK) on their practice list, 50%
(40/79) had < 10, 32% (25/79) had 10–24% and 13% (10/
79) had over 50%. Similarly, of the 75 (19%) who re-
ported the proportion of their practice list that were asy-
lum seekers/refugees, 76% (57/75) had < 10, 9% (7/75)
had 10–24% and only 11% (8/75) had over 50%. There
were no significant differences in practice or other re-
spondent characteristics by professional role (p > 0.2).
Professional knowledge and practice
Issues considered for newly registering patients who are
migrants
When asked which issues were always addressed for
newly registering patients who are migrants (response
rate 78% of GPs and nurses), vaccination history was the
most common always addressed issue (58.2%, 167/287,
95% CI 52.4–63.7), and family planning, TB screening,
sexual health and BBV screening more often considered
on a situation-specific basis (Table 2). The proportion
that never addressed issues ranged from 4.9% (14/287,
2.9–8.0) for vaccination history and family planning to
11.8% (34/287, 8.6–16.1) for TB screening. BBV risk as-
sessments were considered for all newly registering mi-
grant patients by 29.6% (85/287, 24.6–35.1), 27.2% (78/
287, 22.4–32.6) and 30.0% (86/287, 25.0–35.5) for HBV,
HCV and HIV respectively and this did not differ by the
respondent’s profession (p = 0.763, p = 0.953 and p =
0.867 respectively). TB screening was addressed for all
newly registering migrant patients by 28.6% (82/287,
23.7–34.1) of respondents, and this did not differ by pro-
fession (p = 0.072). There were significant differences in
Table 1 Respondent and practice characteristics
Overall
Number (%) 95% CI
1a: Respondent characteristics
Position General Practitioner (GP) 165 (39.9) 35.3–44.6
Nurse 202 (48.8) 44.0–53.6
Practice Manager 29 (7.0) 4.9–9.9
Other clinical 6 (1.4) 0.7–3.1
Other non-clinical 7 (1.7) 0.8–3.4
Not stated 5 (1.2) 0.5–2.8
Total responses 414
Frequency of seeing migrant patients Frequently 108 (34.1) 29.1–39.4
Sometimes 103 (32.5) 27.6–37.8
Rarely 106 (33.4) 28.5–38.8
Total responses 317
1b: Practice characteristics
Location East of England 36 (8.7) 6.3–11.8
London 63 (15.2) 12.1–19.0
Midlands 86 (20.8) 17.1–24.9
North East 23 (5.6) 3.7–8.2
North West 60 (14.5) 11.4–18.2
South East 65 (15.7) 12.5–19.5
South West 30 (7.2) 5.1–10.2
Yorkshire & the Humber 51 (12.3) 9.5–15.8
Total responses 414
Size of practice Small (0–5279 patients) 39 (25.8) 19.5–33.3
Medium (5280–9299 patients) 42 (27.8) 21.3–35.4
Large (> = 9300 patients) 70 (46.4) 38.6–54.3
Total responses 151
Proportion of practice population that are new migrants Low (0–9%) 40 (50.6) 39.8–61.4
Medium (10–24% patients) 25 (31.6) 22.4–42.5
High (25–49% patients) 4 (5.1) 2.0–12.3
Very high (50–100% patients) 10 (12.7) 7.0–21.8
Total responses 79
Proportion of practice population that are asylum seekers/refugees Low (0–9%) 57 (76.0) 65.2–84.2
Medium (10–24% patients) 7 (9.3) 4.6–18.0
High (25–49% patients) 3 (4.0) 1.4–11.1
Very high (50–100% patients) 8 (10.7) 5.5–19.7
Total responses 75
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planning, and sexual health advice and screening (all p <
0.01), with nurses more likely than GPs to address these
issues for all newly registering migrant patients.
Knowledge of migrants’ entitlements to health services
When asked about migrants’ entitlements to health ser-
vices (100% response rate), 88.3% (323/366, 84.5–91.2)
of clinical staff correctly identified emergencydepartments and walk-in centres as free to all and 76.0%
(279/367, 71.4–80.1) correctly identified GP and nurse
consultations in primary care as free to all, with no dif-
ference by profession (p = 0.565 and 0.262 respectively,
Table 2). Surgery or outpatient services in secondary
care were correctly identified as not free to all by 52.3%
(192/367, 47.2–57.4), and this was higher for GPs
(59.4%, 98/165, 51.8–66.6) than nurses (46.5%, 94/202,
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When testing for HBV (64% response rate), 32.6% (73/
224, 26.8–39.0) of clinical staff requested tests for hepa-
titis B surface antigen (HBsAg) only, 33.9% (76/224,
28.0–40.4) requested both HBsAg and hepatitis B core
antibody (HBcAb) testing, 4.5% (10/224, 2.4–8.0) tested
for HBcAb only, 20.1% (45/224, 15.4–25.8) did not know
what test was requested and 8.9% (20/224, 5.9–13.4)
stated ‘other,’ with most in this group stating that the la-
boratory determined the tests (Table 2). These results
did not differ by profession (p = 0.138).
For HCV (64% response rate), 33.0% (36/109, 24.9–
44.3) GPs and 17.4% (20/115, 11.5–25.3) nurses tested
for hepatitis C antibody (anti-HCV) only, 15.6% (17/109,
10.0–23.6) GPs and 13.0% (15/115, 8.1–20.4) nurses
tested for both anti-HCV and HCV RNA, while 10.1%
(11/109, 5.7–17.2) GPs and 11.3% (13/115, 6.7–18.4)
tested for HCV RNA only. There were 29.4% (32/109,
21.6–38.5) of GPs and 47.0% (54/115, 38.1–56.0) of
nurses who did not know which tests were ordered (p =
0.007), and 11.6% (26/224, 8.0–16.5) stated ‘other’; most
of these stated that the laboratory determined the test,
or that a tick-box ‘hep C screen’ was completed.
For HIV (64% response rate), 66.1% (72/109, 56.8–
74.3) GPs and 40.9% (47/115, 32.3–50.0) nurses tested
for HIV antibodies, 18.3% (20/109, 12.2–26.6) GPs and
43.5% (50/115, 34.8–52.6) nurses did not know what
tests were ordered, and 15.6% (35/224, 11.5–21.0) stated
‘other.’ Significantly more nurses than GPs did not know
which tests were required for diagnosis of HCV and HIV
(p < 0.01).
Incentives for testing
Performance payment structure, PHE recommendations,
Clinical Commissioning Group (CCG) recommendations,
local targets, NICE recommendations and national goals
were all endorsed as incentives or motivators to test mi-
grants for BBVs by over 50% of clinical staff (65% response
rate) (Table 2). Performance payment structure (76.1%,
181/238, 70.2–81.0) had the greatest reported influence on
testing, followed by PHE recommendations and CCG rec-
ommendations (both 73.1%, 174/238, 67.1–78.3). Chief
Medical Officer (CMO) recommendations (43.7%, 104/238,
37.5–50.0) and NHS England (NHSE) recommendations
(44.5%, 105/235, 38.3–50.9) had the least. CCG recommen-
dations, local targets, NICE guidance and national goals
were all endorsed by a significantly higher proportion of
nurses than GPs as incentives or motivators (p < 0.05).
Management of patients diagnosed with hepatitis B and C
All persons positive for HBV were referred to secondary
care by 91.7% (99/108, 84.9–95.6) of GPs and 67.0% (77/
115, 57.9–74.9) of nurses (p < 0.01) and this was 94.4%
(102/108, 88.4–97.4) and 67.8% (78/115, 58.8–75.7)respectively for persons positive for HCV (p < 0.01), with
a higher proportion of nurses (28.7%, 33/115, 21.2–37.5)
than GPs (0.9%, 1/108, 0.2–5.1) reporting they didn’t
know for both questions) (p < 0.01, 54% response rate)
(Table 2). Information on whether the patient had
attended was received by 62.0% (67/108, 52.6–70.6) of
GPs and 48.7% (56/115, 39.8–57.7) of nurses (p < 0.01)
and 52.8% (57/108, 43.4–61.9) of GPs and 40.9% (47/
115, 32.3–50.0) of nurses followed up patients who had
not attended (p < 0.01). Close contacts of HBV infected
cases were offered testing by 74.1% (80/108, 65.1–81.4)
of GPs and 70.4% (81/115, 61.5–78.0) of nurses (p =
0.544), and vaccination by 73.1% (79/108, 64.1–80.6) and
74.8% (86/115, 66.1–81.8) respectively (p = 0.781).
Practice policy
Practice policy for offering BBV testing to migrant
patients
HBV testing was offered on a universal/opt-out basis to
all newly registering migrant patients by 17.8% (46/258,
13.6–23.0) of respondents, with 17.1% (44/257, 13.0–
22.2) for HCV and 20.9% (54/258, 16.4–26.4) for HIV
(all 62% response rate, p = 0.498) (Table 3). For existing
patients who were migrants this was significantly lower:
11.2% (29/258, 7.9–15.7) for HBV (p = 0.045), 10.7% (27/
252, 7.5–15.1) for HCV (p = 0.041) and 14.0% (36/258,
10.3–18.7) for HIV (p = 0.048) (62% response rate for
HBV and HIV, 61% for HCV). Universal opt-out testing
for newly registering migrant patients was significantly
higher where respondents saw migrant patients fre-
quently; 36.2% (34/94, 27.2–46.2) for HBV, 35.5% (33/
93, 26.5–45.6) for HCV and 41.5% (39/54, 32.1–51.6) for
HIV than where they saw them sometimes or rarely;
7.9% (13/164, 4.7–13.1) for HBV, 7.3% (12/164, 4.2–
12.4) for HCV and 9.8% (16/164, 6.1–15.3) for HIV, p <
0.0001), and was higher in small practices, with a similar
pattern for existing migrant patients.
Testing practices varied by PHE region. Practice policy for
offering universal opt-out HIV testing for newly registering
migrant patients ranged from 53.1% (17/32, 36.4–69.1) of re-
spondents in Yorkshire and the Humber to 4.9% (2/41, 1.3–
6.1) of respondents in the South East (p < 0.0001), and this
regional pattern was similar for HBV and HCV (supplemen-
tary Table 1). For existing patients who were migrants, uni-
versal opt-out testing was highest in the Midlands (31.7%,
13/41, 19.6–47.0 for HIV) and lowest in the South East
(4.9%, 2/41, 1.3–16.1 for HIV), p < 0.05 for all three BBV.
Identification of migrant patients for BBV testing
When asked if existing migrant patients were identified
for testing opportunistically during consultation, 78.9%
(191/242, 73.4–83.6) of respondents stated they were
(61% response rate), while only 13.6% (33/242, 9.9–18.5)
stated that systematic identification methods, either
Roche et al. BMC Public Health          (2021) 21:336 Page 12 of 23periodic flagging of the GP system by automated soft-
ware, or periodic manual audit of the GP system,
were used (61% response rate) (Table 3). Flagging was
significantly higher among those who saw migrant pa-
tients frequently (20.0%, 18/90, 13.0–29.4) than those
who saw migrant patients sometimes/rarely (9.9%, 15/
152, 6.1–15.6, p = 0.026), and in small practices
(26.3%, 10/38, 15.0–42.0) compared to medium (9.5%,
4/42, 3.8–22.1) or large (10.0%, 7/70, 4.9–19.2) (p =
0.04) and was highest in Yorkshire and the Humber
(25.0%, 8/32, 13.3–42.1) and London (22.5%, 9/40,
12.3–37.5) and lowest in the South East (0.0%, 0/15,
0.0–20.4), South West (2.6%, 1/38, 0.5–13.5), and
North West (3.1%, 1/32, 0.6–15.7) (p = 0.012) (supple-
mentary Table 1).Services offered
Most (87.5%, 133/152, 81.3–91.8) practices provided in-
terpreter services (38% response rate), and 22.0% (53/
241, 17.2–27.6) offered longer appointments to migrants
at registration (61% response rate), but few offered other
services to facilitate BBV testing and care of migrants
(Table 4): 9.5% (23/241, 6.4–13.9) had a specially desig-
nated clinic; 8.7% (21/241, 5.8–13.0) had a designated
GP; 11.6% (28/241, 8.2–16.3) had specific projects to
register migrants; 8.3% (20/241, 5.4–12.5) had outreach
facilities, 7.5% (18/241, 4.8–11.5) had health support
teams and 4.6% (11/241, 2.6–8.0) had incentive schemes
for GPs. Outreach services (p = 0.024) and projects to
register migrants (p = 0.019) were both more common in
small practices, and projects to register new migrants,
specially designated clinics, longer appointments at
registration (all p < 0.01) and outreach services (p =
0.029) were all more common in practices where re-
spondents saw migrant patients frequently. Provision of
longer appointments at registration varied significantly
by region and was highest in Yorkshire and Humber
(46.9%, 15/32, 30.9–63.6), followed by the North East
(41.7%, 5/12, 19.3–68.0) and was lowest in the North
West (6.3%, 2/32, 1.7–20.1) (p < 0.01) (supplementary
Table 2).Routine recording of data
Ethnicity was routinely recorded by 90.1% (137/152,
84.4–93.1) of respondents’ practices, whereas 58.6% (89/
152, 50.6–66.1) reported that they routinely recorded
country of birth (38% response rate), and this was sig-
nificantly higher where respondents saw migrant pa-
tients frequently (p < 0.01) and in small practices (p =
0.042) (Table 4). Hepatitis diagnosis was routinely re-
corded by 74.3% (113/152, 66.9–80.3), and hepatitis pre-
scription by 53.9% (82/152, 46.0–61.7) of respondents’
practices (Table 4).Perceived barriers for migrants to access healthcare
across the care pathway
The content and proportion of responses in each theme
varied according to which part of the care pathway was
considered (Fig. 1, additional file 4).
For perceived barriers for migrants accessing health-
care (74% response rate), language and culture (pre-
dominantly language) were the most commonly
reported (74.4%, 218/293, 69.1–79.1), followed by pa-
tient information and knowledge, particularly of the
availability of health services and how to navigate the
health system (54.9%, 161/293, 49.2–60.5), and psy-
chological barriers, including fear (15.7%, 46/293,
12.0–20.3) (Fig. 1). Other common themes included
accommodation or having no fixed abode (8.2%, 24/
294, 5.5–11.9), prejudice and discrimination (7.5%,
22/293, 5.0–11.1), and patient financial barriers
(10.2%, 30/293, 7.3–14.2).
Language and culture was also the most commonly
cited barrier to accessing BBV services in primary care
(28.3%, 67/237, 22.9–34.3, 60% response rate) followed
by resource issues (27.0%, 64/237, 21.8–33.0), and staff
knowledge and awareness (25.7%, 61/237, 20.6–31.7).
Resource issues often related to time, whereas staff
knowledge often related to a lack of staff training, or
staff not being aware of patients’ migrant status. Psycho-
logical barriers including stigma and fear of diagnosis
were cited by 17.3% (41/237, 13.0–226) of respondents,
and service issues, such as practices not having a policy
for BBV testing, or not identifying migrant patients, were
given by 14.8% (35/237, 10.8–19.8) of respondents.
For patients to access BBV services in secondary care,
again language and culture was the most common
theme (41.5%, 98/236, 35.4–47.9, 60% response rate),
followed by patient information and knowledge, with re-
sponses often relating to patients not understanding the
significance of the diseases and importance of accessing
treatment (28.4%, 67/236, 23.0–34.5). Geographical is-
sues were cited by 24.5% (58/236, 19.5–30.4), including
transport costs and lack of locally available services, and
21.2% (50/236, 16.5–26.8) cited service issues, including
communication methods around arranging appoint-
ments, waiting times and lack of an organised clinic.
Perceived barriers for asylum seekers accessing
healthcare (74% response rate) were largely similar to
those for all migrants, with some notable differences
(Fig. 2). Language and psychological barriers were
more frequently reported for asylum seekers than they
were for all migrants. Psychological barriers again in-
cluded fear, as well as highlighting mental health con-
cerns for asylum seekers. To a lesser degree,
accommodation, and prejudice and discrimination
were also identified more often for asylum seekers


































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Roche et al. BMC Public Health          (2021) 21:336 Page 17 of 23
Roche et al. BMC Public Health          (2021) 21:336 Page 18 of 23Discussion
Primary care staff knowledge, attitudes, policy and prac-
tice regarding migrants’ healthcare entitlements and
their BBV testing and care was very variable in this sam-
ple of English practices. One in four were unaware that
GP and nurse consultations are free for all. Universal
opt-out BBV testing for migrants was not common prac-
tice, and only one in three clinical staff would routinely
consider BBV risk assessments for newly registering mi-
grant patients. Where testing was requested, most re-
spondents requested the recommended tests, and over
90% indicated they would refer diagnosed cases to sec-
ondary care. Respondents identified access barriers relat-
ing to a range of factors including language; patient
knowledge, stigma and fear; time pressures of appoint-
ments, practices not having a BBV testing policy and
lack of knowledge and awareness among staff.
Knowledge of entitlements to health services varied. Of
particular concern is that a quarter of clinical staff were
unaware that GP and nurse consultations are free to all.
Vulnerable patients, including migrants could be wrongly
refused GP registration, despite national guidance that
lack of documentation should not be a barrier to register-
ing with a GP [24]. Three UK studies estimate that refusal
ranges from 20 to 39% [25–27]. As primary care is the first
point of access, ‘gatekeeper’ to other services, and a
trusted source of health information, GP staff’s poor
knowledge of entitlements is likely to create a further ac-
cess barrier in addition to the system, cultural and lan-
guage barriers migrants face, especially when it comes to
communicable disease control [28, 29]. There were no
substantial differences in knowledge of healthcare entitle-
ments of migrants between GPs and nurses; GPs were
more likely to know that operations and outpatient ap-
pointments are not free, and nurses were more likely to
know that care for FGM, torture etc. is free, which likely
reflects their roles in general practice.
BBV testing was more often conducted on an ad-hoc
than opt-out basis, and BBV risk assessments for newly
registering migrant patients were routinely considered
by only a third of respondents, and more often consid-
ered on a situation specific basis. Most respondents
stated existing migrant patients were identified for test-
ing opportunistically during consultation, and only 14%
systematically flagged migrant patients for BBV testing.
These findings suggest that migrant patients eligible for
BBV testing are not often routinely identified as such,
which is likely to hinder adherence to BHIVA, ECDC
and NICE guidelines which recommend BBV testing for
migrant patients from higher HBV and HCV prevalence
(> = 2%) areas and HIV testing for all patients in high (>
2 per 1000) prevalence areas in the UK [10, 11, 30], and
is consistent with other studies which report low ad-
herence to testing guidelines for BBVs outside of thesexual and antenatal health setting [12, 31]. Opt-out
rapid testing in general practice has been shown to
increase diagnosis rates for HIV, and universal opt-
out testing initiatives for migrants which offer oppor-
tunities to normalise testing are subject to ongoing
evaluations and have been well received by staff and
patients [32–34].
Improved practice staff knowledge is needed to help
reduce barriers and variations in service provision. Re-
sources are available, such as the PHE Migrant Health
Guide which outlines NHS entitlements and gives guid-
ance on assessing new patients from overseas [35],
RCGP e-learning courses [36], but also PHE and char-
ities co-branded promotional videos, posters and leaflets
on BBV in multiple languages for patient waiting areas
can be downloaded or ordered from gov.uk [37]. Further
work is needed to understand current awareness and to
increase uptake of these resources.
Use of software programmes to identify and automat-
ically flag patients for testing based on risk factors or
risk proxies recorded on practice registers has been
shown to be effective for groups including migrants in
primary care and other settings [38–40]. This requires
migrant status to be recorded on GP systems for mi-
grants to be flagged as at risk. Although 59% of respon-
dents stated that their practice routinely recorded
country of birth, data from the Clinical Practice Re-
search Datalink suggests recording is a lot lower at 1.6%
[41]. This discrepancy could in part be due to biases in
our sample or respondents giving socially desirable an-
swers, however it may be that practices are recording
this data on other systems where the data is not extract-
able. This highlights a need to increase awareness of the
importance of recording patient country of birth
amongst practitioners and information service providers,
and for practitioners to assess risks associated with
country of birth as a part of the first registration
consultation.
Flagging and opt-out testing for newly registering mi-
grant patients was more frequently reported where re-
spondents said they see migrant patients frequently, in
smaller practices and highest in Yorkshire and Humber
and London, but lowest in the South East. A similar pat-
tern was observed for services such as specially desig-
nated clinics, longer appointments at registration and
projects to register migrants – these were more fre-
quently reported where respondents saw migrants fre-
quently. Outreach services and projects to register
migrants were higher in small practices. These variations
may reflect GP surgeries adopting policies and practices
that reflect the needs and diversity of their local popula-
tions, and the ability of smaller practices to be more re-
sponsive and adaptive in implementing migrant focused
services.
Fig. 1 Perceived barriers for migrant populations to access different parts of the BBV care pathway, England, 2017
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fluential way to incentivise BBV testing [42–44], and
PHE and CCG recommendations were also more often
stated to provide motivation to test than alternative
sources. Only half of respondents indicated that NHSE
and CMO recommendations would provide motivation
for testing, which may reflect a relative lack of confi-
dence in these bodies versus the perceived scientific
credibility and independence of PHE and the more dir-
ect relationship and understanding of local PHE teams
with CCGs. Interestingly, nurses were more likely than
GPs to be motivated by local targets, national goals,
CCG recommendations and NICE guidance.Fig. 2 Perceived barriers to accessing health care for all migrants and for aOver 90% of GPs reported referring diagnosed cases of
HBV and HCV to secondary care, and over half followed
patients up if they did not attend secondary care ap-
pointments. Three quarters would offer close contacts of
HBV infected cases testing, and three quarters would
offer close contacts hepatitis B vaccination. These pro-
portions seem high, as many patients diagnosed with
HBV and HCV are known not to be accessing secondary
care – in a 2012 UK study only a third of HBV diag-
nosed patients were on treatment [45] and an analysis of
England sentinel surveillance data showed that between
2004 and 2017 only 21% of viraemic HCV diagnosed pa-
tients had evidence of treatment [46], and baseline HBVsylum seekers, England, 2017
Roche et al. BMC Public Health          (2021) 21:336 Page 20 of 23testing of close contacts was only 34% in a 2018 UK
study [47]. Our results may be due to sampling and re-
sponder bias, due to initially contacting networks who
were interested in migrant health, and those who were
interested being more likely to respond, as well as wish-
ing to give socially acceptable or desirable responses.
Differences in knowledge of BBV diagnosis and man-
agement were noted between nurses and GPs, with
nurses being less likely to know whether all diagnosed
HBV/HCV patients are referred and whether referrals
are followed up, and less likely to know the diagnostic
tests to request for HCV and HIV but there was no sig-
nificant difference for HBV. Generally, there is a need
for improved understanding of diagnostic testing for
BBV in practices. Regardless of service, respondents
cited language as the main barrier to accessing health-
care, which is consistent with the literature [14, 15, 48].
For patients who require linguistic support, interpreting
services are recommended in General Medical Council
guidance and were provided by 88% of respondents’
practices [49–51]. Nevertheless, there is evidence that
interpreting services are underused, despite incurring no
direct cost for practices [52]. This may be partly due to
time pressures within appointments and the indirect
costs of longer appointment times, as well as the
need for forward planning and a lack of professional
confidence in working with interpreters [53]. Brief
education may help improve professional confidence
in when and how to use interpreters [54]. Improved
provision of translated materials is also likely to be
beneficial in improving patient access to health infor-
mation; efforts to ensure materials about BBV are
translated are ongoing [55].
Patient knowledge and understanding of disease, and
the location of secondary care services were cited as bar-
riers to accessing secondary care. Community based
treatment pathways, as have been demonstrated to be ef-
fective for HCV [56, 57], could help to overcome geo-
graphic barriers, although one recent study found that
(first and second generation) migrant patients were no
more likely to complete treatment on a community
pathway [40]. Assessing patient attitudes towards BBV,
and increasing patient knowledge would also be valuable
and could be considered by practices to improve their
services.
Limitations
This survey has a low response rate and a relatively
small sample size, and may be affected by sampling and
responder bias, as the survey was disseminated by con-
tacts and networks with an interest in migrant and asy-
lum seeker health and through a publication which
professionals with an interest in vaccines subscribe to, so
practice professionals with interests in migrant health,BBVs and vaccine preventable diseases may have been
more likely to respond. This is likely to bias the re-
sponses towards more knowledge of healthcare entitle-
ments and better practices for BBV screening and
management of migrants. Response to recruitment at
professional conferences was poor, possibly due to com-
peting priorities for professionals with limited time in a
conference setting.
No demographic data on respondents was collected,
so it was not possible to assess how responses vary by
individual respondent characteristics, which may have
associations with personal bias, stigma and discrimin-
ation against individuals who have migrated from spe-
cific countries or settings.
Our findings may therefore not be representative of all
general practice staff. It was not possible to obtain data
on non-respondents which would help to identify biases
in responses; further work to survey practitioners within
a fixed sampling frame (for example all GP practices in
one CCG) may help to address this issue. In addition,
not all questions were completed by all participants and
fewer respondents completed later questions in the sur-
vey. Again, those more motivated may be more likely to
complete the whole survey, leading to potentially greater
bias in questions that had fewer respondents.
The small sample size limited our power to detect sta-
tistically significant differences between subgroups, par-
ticularly in detecting regional variations. Increasing the
responses to the survey would help to address this, and
in hindsight, following up the circulation of the survey
link in Vaccine Updates could have helped to increase
sample size and potentially reduce response bias.
Another limitation was that questions about barriers
for migrant patients were asked to general practice pro-
fessionals rather than migrants themselves; responses
will reflect only barriers that these professionals were
aware of and may exclude those which migrants experi-
ence, but professionals are less aware of. However, our
findings echoed those cited by migrants in a qualitative
study on barriers to accessing healthcare for viral hepa-
titis [14], which suggests that our respondents were rela-
tively well informed about these issues.
Conclusions
Systematic or universal opt-out testing for migrant pa-
tients are uncommon and testing is more often done on
an ad hoc basis, despite BASHH, PHE and NICE guide-
lines. Achieving the WHO goal of eliminating viral hepa-
titis as a public health threat by 2030 requires coordinated
efforts to increase case-finding of patients with HBV and
HCV; our results suggest that current testing practices for
high-risk migrants in primary care are likely to be inad-
equate to meet the elimination goal among this popula-
tion. Improved systematic risk-based flagging of migrant
Roche et al. BMC Public Health          (2021) 21:336 Page 21 of 23patients for BBV screening and checks or prompts for re-
ferral and attendance to specialist services is needed to re-
duce the burden of undiagnosed infection and improve
uptake of treatment, noting this is curative for hepatitis C.
Local and national commissioning specifications for pri-
mary care testing and management of BBV infected pa-
tients may be required to achieve this goal. General
practice professionals’ knowledge of migrants’ entitle-
ments to healthcare was variable and could affect mi-
grants’ access to care. Perceived barriers to accessing
healthcare consistently included language and lack of pa-
tient and staff information and awareness. These are not
insurmountable but require sustained commitment, pro-
fessional awareness as well as resource. The ultimate goal
is to reduce morbidity, mortality and inequalities associ-
ated with BBV infections in migrant populations, mindful
of the fact that this population is already vulnerable to dis-
parities in healthcare access and health outcomes.Supplementary Information
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